Back

News overview

DENSE among the last three nominees Science and Innovation Prize 2021

Read more


Carla van Gils new director KWF

Prof. Dr. Carla van Gils will be part of the management of KWF Kankerbestrijding from 1 June. She will combine this function with her research work at the Julius Centrum UMC Utrecht.

Read more


Initial results of BCM-PRIME study: Tuberculosis vaccine does not protect vulnerable elderly people against COVID-19

The BCG vaccine does not offer vulnerable elderly people protection against the symptoms of COVID-19. These are the initial results of the BCG-PRIME study among 6,132 vulnerable patients aged 60 and over.

Read more


Plasma antibody does not help the sickest COVID-19 patient

Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not improve outcomes. Enrollment continues for moderately ill hospitalized COVID-19 patients in the trials.

Read more


Eerste resultaten BCG-PRIME studie: Tuberculosevaccin biedt kwetsbare ouderen geen bescherming tegen COVID-19

Het BCG-vaccin biedt kwetsbare ouderen geen bescherming tegen ziekteverschijnselen door COVID-19. Dat zijn de eerste resultaten van de BCG-PRIME studie onder 6132 kwetsbare patiënten van 60 jaar en ouder.

Read more


When does home monitoring work for patients with heart failure?

The UMC Utrecht is launching a large-scale study into the effectiveness of telehealth coaching in patients with heart failure.

Read more


Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrollment of Critically Ill COVID-19 Patients

Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.

Read more


UMC Utrecht starts clinical trial with COVID-19 vaccine

UMC Utrecht will start a study with the COVID-19 candidate vaccine from CureVac on 28 December. A total of approximately 2,000 volunteers in the Netherlands will be recruited to participate in this study.

Read more


Method for better prediction models

Predicting the extent to which a person is at risk of a particular disorder or predicting the course of an individual’s disease; the use of prediction models is increasing in the healthcare sector.

Read more


Help older people better with their medication intake

Personal guidance has added value, particularly for elderly people with multiple chronic conditions.

Read more


juliuscentrum.umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren. Deze gegevens worden niet aan derden verstrekt.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet